Last week, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.
Last Wednesday, the FDA granted emergency approval of a vaccine alternative. A combination of monoclonal antibodies develop in part by Vanderbilt will help those who may not respond well to the COVID vaccine like the immunocompromised.
Vanderbilt University Medical Center in Nashville contributed to a new COVID-19 treatment pill. It’s now under review for use in the U.S.
Great news. A new technology developed at Vanderbilt may push monoclonal antibody therapies to the next level in the fight against COVID-19.
Vanderbilt recently announced a vaccination mandate for all employees including those at Vanderbilt Tullahoma and Vanderbilt Bedford County.